Top Markets
#1 ADO Protocol ADO Protocol +329.02%
#2 GoPlus Security GoPlus Security +52.75%
#3 The Black Bull The Black Bull +38.37%
#4 Nockchain Nockchain +38.36%
#5 Starpower Starpower +34.57%
#6 Tutorial Tutorial +34.42%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +33.83%
#8 Fake World Assets Fake World Assets +26.29%
#9 GAIB AID GAIB AID +24.67%
#10 Verus Coin Verus Coin +20.41%
Coin of the day
ADO Protocol ADO Protocol
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Marvel Biosciences Corp. Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL
Rangering i aksjer #33652
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical... Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company’s lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer’s disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Aksjekurs
$0.11376022
Markedsverdi
$7.17M
Endring (1 dag)
-8.82%
Endring (1 år)
-26.88%
Land
CA
Handel Marvel Biosciences Corp. (MRVL)

Kategori

Healthcare
P/B-forhold for Marvel Biosciences Corp. (MRVL)
P/B-forhold per 2026 TTM: 0
Ifølge Marvel Biosciences Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Marvel Biosciences Corp. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE